Avricore Health Inc.
AVCR.VTSXVHealthcare● Active
$0.05
$-0.01(-16.67%)
Market Cap$5064483
P/E Ratio—
52W High$0.1
52W Low$0.045
Avricore Health Inc. (AVCR.V) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AVCR.V · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.53M | $4.79M | $3.49M | $1.77M | $0.12M |
| Cost of Revenue | $0.30M | $2.91M | $2.28M | $1.31M | $0.09M |
| Gross Profit | $0.24M | $1.88M | $1.20M | $0.46M | $0.03M |
| Gross Margin %(computed) | 44.27% | 39.29% | 34.53% | 25.83% | 24.85% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $1.75M | $1.84M | $1.01M | $1.71M |
| Total Operating Expenses | $1.60M | $1.74M | $1.89M | $1.27M | $1.77M |
| Operating Income | ($1.37M) | $0.14M | ($0.69M) | ($0.81M) | ($1.75M) |
| Operating Margin %(computed) | -256.15% | 2.91% | -19.85% | -45.80% | — |
| Interest Income | $0.01M | $0.00M | $0.00M | $0.01M | $0.00M |
| Interest Expense | $0.01M | $0.01M | $0.01M | $0.01M | $0.05M |
| Income Before Tax | ($1.86M) | ($0.67M) | ($0.70M) | ($0.82M) | ($1.71M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($1.86M) | ($0.67M) | ($0.70M) | ($0.82M) | ($1.71M) |
| Net Margin %(computed) | -348.16% | -13.98% | -20.12% | -46.27% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Wtd Avg Shares | 101.29M | 100.31M | 99.56M | 97.86M | 92.61M |
| EBITDA | ($1.23M) | ($0.21M) | ($0.28M) | ($0.63M) | ($1.64M) |
| EBITDA Margin %(computed) | -230.00% | -4.36% | -7.89% | -35.61% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · M
Explore more Avricore Health Inc. data
About Avricore Health Inc. (AVCR.V) Income Statement
Avricore Health Inc. (AVCR.V) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AVCR.V reported revenue of $0.00B, gross profit of $0.00B (gross margin 44.27%), and net income of ($0.00B) — a net profit margin of -348.16%.
Frequently asked questions
AVCR.V · 4 questionsAvricore Health Inc. (AVCR.V) reported revenue of $0.00B for 2025, down 88.8% year-over-year.
AVCR.V revenueAVCR.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08